FR1587052A - - Google Patents

Info

Publication number
FR1587052A
FR1587052A FR1587052DA FR1587052A FR 1587052 A FR1587052 A FR 1587052A FR 1587052D A FR1587052D A FR 1587052DA FR 1587052 A FR1587052 A FR 1587052A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
John Wyeth and Brother Ltd
Original Assignee
John Wyeth and Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Wyeth and Brother Ltd filed Critical John Wyeth and Brother Ltd
Application granted granted Critical
Publication of FR1587052A publication Critical patent/FR1587052A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR1587052D 1967-06-14 1968-04-10 Expired FR1587052A (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2738267 1967-06-14
GB3759867 1967-08-16

Publications (1)

Publication Number Publication Date
FR1587052A true FR1587052A (xx) 1970-03-13

Family

ID=26258780

Family Applications (2)

Application Number Title Priority Date Filing Date
FR147664A Expired FR8056M (xx) 1967-06-14 1968-04-10
FR1587052D Expired FR1587052A (xx) 1967-06-14 1968-04-10

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR147664A Expired FR8056M (xx) 1967-06-14 1968-04-10

Country Status (15)

Country Link
JP (1) JPS4938268B1 (xx)
BE (1) BE713392A (xx)
CH (1) CH560204A5 (xx)
DE (1) DE1770177A1 (xx)
DK (1) DK137674B (xx)
ES (1) ES352579A1 (xx)
FR (2) FR8056M (xx)
GB (1) GB1226548A (xx)
IE (1) IE32086B1 (xx)
IL (1) IL29654A (xx)
IT (1) IT1053686B (xx)
LU (1) LU55869A1 (xx)
NL (1) NL6805103A (xx)
PL (1) PL71145B1 (xx)
SE (1) SE374745B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE794096A (fr) * 1972-08-07 1973-05-16 Lepetit Spa Oxazoles 2,4,5-trisubstitues et leur preparation
JPS58183676A (ja) * 1982-04-19 1983-10-26 Takeda Chem Ind Ltd オキサゾ−ル誘導体
EP0513387B1 (en) 1990-11-30 2000-03-01 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives as active oxygen inhibitors
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Also Published As

Publication number Publication date
IT1053686B (it) 1981-10-10
ES352579A1 (es) 1970-01-01
IE32086L (en) 1968-12-14
JPS4938268B1 (xx) 1974-10-16
IL29654A (en) 1974-05-16
PL71145B1 (en) 1974-04-30
LU55869A1 (xx) 1968-07-09
DK137674B (da) 1978-04-17
BE713392A (xx) 1968-10-08
DE1770177A1 (de) 1972-03-16
SE374745B (xx) 1975-03-17
DK137674C (xx) 1978-09-25
FR8056M (xx) 1970-07-06
CH560204A5 (xx) 1975-03-27
GB1226548A (xx) 1971-03-31
NL6805103A (xx) 1968-12-16
IE32086B1 (en) 1973-04-04

Similar Documents

Publication Publication Date Title
AU425114B2 (xx)
AT298283B (xx)
DK137674C (xx)
AU416737B2 (xx)
AU342066A (xx)
AU3189468A (xx)
AU610966A (xx)
BE692409A (xx)
BE614676A (xx)
BE699865A (xx)
BE692778A (xx)
BE692654A (xx)
BE692577A (xx)
BE692553A (xx)
BE692552A (xx)
BE692493A (xx)
BE692492A (xx)
AU459699A (xx)
BE692375A (xx)
BE692374A (xx)
BE692332A (xx)
BE692199A (xx)
BE692198A (xx)
BE692779A (xx)
BE609934A (xx)

Legal Events

Date Code Title Description
ST Notification of lapse